Table 14.6

De Novo Post Transplant Solid Malignancy, 1997 to 2006

Malignancies by Type	Year of Transplant
Malignancies by Type	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006
Total # of Post-Tx Malignancies	824	871	783	828	711	526	454	338	175	76
Squamous/Basal Cell Carcinoma	466	472	420	430	357	276	208	173	77	27
Melanoma	20	18	22	29	19	15	21	6	8	4
Kaposi Sarcoma	5	12	7	10	6	2	3	4	-	2
Central Nervous System	4	7	7	8	8	6	2	2	2	-
Genito-Urinary (1)	117	128	113	119	93	76	76	49	36	14
Gastro-Intestinal (2)	49	49	67	53	52	36	36	25	16	8
Primary Hepatic Tumor	8	9	4	9	8	6	2	3	1	5
Metastatic Hepatic Tumor	10	15	9	11	16	8	5	5	2	3
Larynx/Bronchi/Lung	50	63	61	57	65	33	39	27	15	4
Breast/Thyroid	44	47	34	44	43	29	29	17	6	4
Leukemia	4	3	3	5	7	6	2	4	3	1
Sarcoma (3)	1	3	2	2	4	-	3	2	-	-
Other	37	42	26	40	26	25	13	19	6	2
Unknown	9	3	8	11	7	8	15	2	3	2
Squamous/Basal Cell Carcinoma	56.6%	54.2%	53.6%	51.9%	50.2%	52.5%	45.8%	51.2%	44.0%	35.5%
Melanoma	2.4%	2.1%	2.8%	3.5%	2.7%	2.9%	4.6%	1.8%	4.6%	5.3%
Kaposi Sarcoma	0.6%	1.4%	0.9%	1.2%	0.8%	0.4%	0.7%	1.2%	-	2.6%
Central Nervous System	0.5%	0.8%	0.9%	1.0%	1.1%	1.1%	0.4%	0.6%	1.1%	-
Genito-Urinary (1)	14.2%	14.7%	14.4%	14.4%	13.1%	14.4%	16.7%	14.5%	20.6%	18.4%
Gastro-Intestinal (2)	5.9%	5.6%	8.6%	6.4%	7.3%	6.8%	7.9%	7.4%	9.1%	10.5%
Primary Hepatic Tumor	1.0%	1.0%	0.5%	1.1%	1.1%	1.1%	0.4%	0.9%	0.6%	6.6%
Metastatic Hepatic Tumor	1.2%	1.7%	1.1%	1.3%	2.3%	1.5%	1.1%	1.5%	1.1%	3.9%
Larynx/Bronchi/Lung	6.1%	7.2%	7.8%	6.9%	9.1%	6.3%	8.6%	8.0%	8.6%	5.3%
Breast/Thyroid	5.3%	5.4%	4.3%	5.3%	6.0%	5.5%	6.4%	5.0%	3.4%	5.3%
Leukemia	0.5%	0.3%	0.4%	0.6%	1.0%	1.1%	0.4%	1.2%	1.7%	1.3%
Sarcoma (3)	0.1%	0.3%	0.3%	0.2%	0.6%	-	0.7%	0.6%	-	-
Other	4.5%	4.8%	3.3%	4.8%	3.7%	4.8%	2.9%	5.6%	3.4%	2.6%
Unknown	1.1%	0.3%	1.0%	1.3%	1.0%	1.5%	3.3%	0.6%	1.7%	2.6%
Total # of Patients	567	619	563	582	526	408	353	269	153	69